Locksley Resources (ASX: LKY) hits 99.5% purity antimony trioxide milestone, opening U.S. defense supply chain pathway
How Accenture is using Google Cloud and Wiz to close security blind spots in modern multi-cloud infrastructure
Read More 5 minute read General business news enGene (Nasdaq: ENGN) secures credit facility from Hercules Capital to support bladder cancer gene therapy and 2026 FDA filing enGene secures $125M debt facility from Hercules Capital to fund detalimogene bladder cancer gene therapy. Find out what this means for its 2026 FDA filing. byVenkateshJanuary 21, 2026